Mast Therapeutics
(NYSE:MSTX)
CEO: Brian Culley
THIS INTERVIEW HAS EXPIRED
This interview includes forward-looking statements, within the meaning of federal securities laws, about Mast Therapeutics’ business prospects, financial position, and pharmaceutical development programs. Any statement that is not a statement of historical fact should be considered a forward-looking statement. Because forward-looking statements relate to the future, they are only predictions that reflect the Company’s beliefs based on current information and speak only as of the date on which they are made. Accordingly, you are cautioned not to place undue reliance on forward-looking statements. For a description of risks and uncertainties that could cause material differences between the Company’s actual results and those stated or implied by the forward-looking statements, please see the Company’s press releases and filings with the Securities and Exchange Commission, including its annual report on Form 10-K filed on March 24, 2015. These filings are available on the Company’s website, www.masttherapeutics.com, and at www.sec.gov.
